Andrzej Rutkowski, MSc, PhD, is a Senior Scientist in the Biomarker group at Medicines Discovery Catapult.
In his career as an academic, he worked in a variety of fields, such as angiogenesis, adult stem cells, oncofetal antigens and herpes virus molecular biology. After volunteering in a diagnostic lab, he decided to move away from basic science and focus on research that can produce much more direct benefits to the patients. He transitioned to industry to support the development of drugs and diagnostic technologies focusing on biomarkers – including genetic biomarkers of cancer.
